Efficacy of tocilizumab monotherapy in patients with microscopic polyangiitis (MPA) compared to healthy controls and rheumatoid arthritis patients

Trial Profile

Efficacy of tocilizumab monotherapy in patients with microscopic polyangiitis (MPA) compared to healthy controls and rheumatoid arthritis patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Sep 2016

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Microscopic polyangiitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top